|
|
Home
> Anti-aging Research > Celebrex™.
COX-2 Inhibitors (Celebrex™ (celecoxib)/Vioxx™
(rofecoxib)/Mobic (meloxicam), etc.)
Specific Recommendations:
Popular Supplements:
Alternative News:
-
Chondroitin/Glucosamine
Reduced Pain in Knee Arthritis in RCT - Medscape, 1/30/15 -
"a combination glucosamine/chondroitin sulfate
product produced a 50.1% decrease in Western Ontario and McMaster OA index
(WOMAC) pain, which is comparable to the 50.2% decrease seen in patients
randomly assigned to receive celecoxib ... Patients received either
chondroitin sulfate 400 mg plus glucosamine hydrochloride 500 mg (CS+GH;
Droglican, Bioibérica SA) three times a day or celecoxib 200 mg every day
for 6 months" - See
glucosamine chondroitin formulas at Amazon.com.
-
Why
omega-3 oils help at the cellular level - Science Daily, 5/15/12 -
"The scientists fed mouse macrophages -- a kind of
white blood cell -- three different kinds of fatty acid: eicosapentaenoic
acid (EPA), docosahexaenoic acid (DHA) and arachidonic acid (AA). EPA and
DHA are major polyunsaturated omega-3 fatty acids, essential to a broad
range of cellular and bodily functions, and the primary ingredient in
commercial fish oil dietary supplements. AA is a polyunsaturated omega-6
fatty acid prevalent in the human diet ... They discovered that omega-3
fatty acids inhibit an enzyme called cyclooxygenase (COX), which produces
the prostaglandin hormones that spark inflammation. The action is similar to
what happens when one takes an aspirin, which disrupts the COX-2 signaling
pathway, thus reducing inflammation and pain ... On the other hand ...
omega-3 oils do not inhibit another group of enzymes called lipoxygenases
(LOX), which are also produced by stimulated macrophages. One type of
generated LOX enzyme in turn produces fat-signaling molecules called
leukotrienes, which are pro-inflammatory. But Norris noted that LOX enzymes
may also generate anti-inflammatory compounds called resolvins from EPA and
DHA" - See
Mega Twin EPA at Amazon.com
and
Jarrow Max DHA at Amazon.com.
-
Pomegranate extract may stop inflammation, says Bugs - Nutra USA,
6/13/08 - "COX-1 and COX-2 activity was
significantly reduced in the pomegranate-fed animals, compared to control,
particularly for COX-2. Indeed, COX-1 activity was reduced by about seven
per cent following ingestion of the extract, while COX-2 activity decreased
by about 26 per cent" - [Science
Daily] - See
pomegranate at Amazon.com.
-
3 Herbal Medicines
May Ease Back Pain - WebMD, 4/18/06 -
"A 60-milligram daily dose of devil's claw also
appeared to cut back pain as much as a 12.5-milligram daily dose of Vioxx, a
painkiller no longer on the market due to a rise in the risk of
cardiovascular events -- such as heart attackheart attack and strokestroke
-- in some patients"
-
Pycnogenol reduces osteoarthritis pain, study - Nutra USA, 2/6/06 -
"300 mg pine bark extract supplements ... Thirty
minutes after taking the supplement, the mean inhibition of COX-1 and COX-2
was 22.5 and 15 per cent"
-
How CLA fights inflammatory disease - Nutra USA, 10/19/05 -
"one of the CLA isomers is a natural regulator of
the COX-2 protein"
-
Aspirin Might Prevent Vioxx Cardiac Damage - Science Daily, 9/14/05
- Are Anti-Inflammatory
Herbs Safe for the Heart? - Dr. Weil, 5/20/05
- Alternatives for
Arthritis Pain? - Dr. Weil, 11/11/04
-
S-Adenosyl Methionine May Be As Efficacious As Celecoxib in Management of
Knee Osteoarthritis, But Onset of Action Is Slower - Doctor's Guide,
5/4/04 -
"During the first month of phase 1, celecoxib was
significantly more effective in reducing pain than was SAMe (P= .024);
however, by the second month of phase 1, patients in both groups had
significant pain improvement from baseline (PS</i>] < .01), and no
significant difference in pain was observed between groups" - See
iHerb or
Vitacost
SAMe products.
- “Herbal Aspirin”
Effective for Low Back Pain - New Hope Natural Media, 9/19/02 -
"randomly assigned to daily treatment with four
capsules of a standardized extract of
willow bark (containing 240 mg of salicin per
day) or one 12.5-mg tablet of the anti-inflammatory drug rofecoxib (Vioxx®)
for four weeks. In all measures of pain relief, willow bark treatment was
found to be as effective as rofecoxib" - See
iHerb
and
Vitacost
willow bark products.
-
A Report on Curcumin's Anti-cancer Effects - Life Extension Magazine,
7/02 - See curcumin at
iHerb or
Vitacost.
-
Willow Bark Cheap Alternative To Pain Killers For Low Back Pain -
Intelihealth, 1/31/02 -
"Noting that willow bark is roughly 40% less
expensive than rofecoxib [Vioxx], the researchers conclude that
willow bark and rofecoxib are equally safe and effective in the
treatment of low back pain, but that willow bark
extract "has the current advantage of being cheaper than rofecoxib.""
-
COX-2 inhibitors and cancer treatment - Life Extension Magazine, 10/00
-
Natural COX-2 Inhibitors The Future of Pain Relief - Nutrition Science
News, 8/00
-
Using Arthritis Drugs To Treat Cancer - Life Extension Magazine, 3/00
CME:
News & Research:
-
Celecoxib may prevent lung cancer in former smokers - Science Daily,
7/6/11
-
Anti-inflammatory drug may fight breast cancer - Science Daily, 5/5/11
-
Widely used arthritis pill protects against skin cancer, study suggests
- Science Daily, 12/2/10 - "Celecoxib, a
prescription-strength nonsteroidal anti-inflammatory drug (NSAID), reduced
basal cell carcinomas by 68 percent and squamous cell carcinomas by 58
percent in patients at high risk for skin cancer. The decrease in the
incidence of these cancers is much greater than that achieved through the
use of sunscreen, which provides only moderate protection against squamous
cell and basal cell carcinomas"
-
Celebrex inhibited the burden of skin cancer in high-risk patients -
Science Daily, 1/5/10
-
Celebrex May Slow, Prevent Skin Cancers - WebMD, 1/5/10 -
"There is mounting evidence that nonsteroidal
anti-inflammatory drugs (NSAIDs) may help prevent or slow the growth of non-
melanoma skin cancers ... the Cox-2 arthritis drug Celebrex was found to
reduce the growth of basal cell skin cancers by 50% in some patients with a
rare genetic condition that makes them highly susceptible to the tumors"
-
Increased Mortality and Cardiovascular Morbidity Associated With Use of
Nonsteroidal Anti-inflammatory Drugs in Chronic Heart Failure - Arch
Intern Med. 2009 Jan 26;169(2):141-9 - "The hazard
ratio (95% confidence interval) for death was 1.70 (1.58-1.82), 1.75
(1.63-1.88), 1.31 (1.25-1.37), 2.08 (1.95-2.21), 1.22 (1.07-1.39), and 1.28
(1.21-1.35) for rofecoxib, celecoxib, ibuprofen, diclofenac, naproxen, and
other NSAIDs, respectively. Furthermore, there was a dose-dependent increase
in risk of death and increased risk of hospitalization because of myocardial
infarction and HF. Propensity-based risk-stratified analysis and
case-crossover models yielded similar results"
-
Prostate Cancer Can Be Halted With Anti-inflammatory And Statin Used In
Tandem, Study Suggests - Science Daily, 4/14/08 -
"A combination of low doses of Lipitor and Celebrex
had a more potent inhibiting effect on the formation of later stage tumors
than a higher dose of either agent alone ... The results from our study
indicate that a combination of Lipitor and Celebrex may be an effective
strategy for the prevention of prostate cancer progression from the first to
the second stage"
-
Popular Arthritis Drug May Disrupt Heart Rhythm, New Research Finds -
Science Daily, 1/24/08 - "Celebrex, a popular
arthritis drug that blocks pain by inhibiting an enzyme known as COX-2, has
been shown in laboratory studies to induce arrhythmia, or irregular beating
of the heart"
-
Vioxx Side-effects: Possible Explanation - Science Daily, 8/27/07
-
COX
Inhibitors May Weaken Protective Qualities Of Estrogen Hormone Therapy -
Science Daily, 5/23/07
-
Green Tea And COX-2 Inhibitors Combine To Slow Growth Of Prostate Cancer
- Science Daily, 3/1/07 - "In mice that were not
treated with either substance, the tumor volume averaged 1,300 cubic
millimeters, whereas mice given either the tea or celecoxib had tumors
averaging 835 cubic millimeters and 650 cubic millimeters, respectively.
Tumors taken from mice given both agents, however, measured on average a
volume of 350 cubic millimeters"
- Mixed reviews for Vioxx
successor - MSNBC, 11/13/06
-
Study Finds That Vioxx Reduces The Risk Of Colorectal Polyps - Science
Daily, 8/31/06
-
New Study Re-evaluates Cardiovascular Risks of Anti-inflammatory Drugs -
Doctor's Guide, 6/2/06
-
Analysis Clarifies Cox-2 Heart Risk - WebMD, 6/1/06
-
Celebrex May Up Blood Pressure - WebMD, 5/19/06
- Celebrex may fight
cancer, but with risks - MSNBC, 4/3/06
-
Regular Use Of Selective COX-2 Inhibitors Decreases Risk Of Breast Cancer
- Science Daily, 1/30/06 - "a daily dose of 200 mg
celecoxib reduced the risk of breast cancer by 83% and a daily dose of 25 mg
rofecoxib reduced the risk of breast cancer by 64%. Regular use of
non-selective COX-2 inhibitors - aspirin (325 mg), ibuprofen (200mg) and
naproxen (250 mg) - also significantly reduced the risk of breast cancer,
but less so than regular intake of selective COX-2 inhibitors"
-
'Vioxx Like' Drugs May Still Be Best Option for Arthritis, Write Scientists
- Doctor's Guide, 1/18/06
-
No Evidence that COX-2 inhibitors Provide Greater Stomach Protection -
Doctor's Guide, 12/2/05
-
New Pain Pills: Not Easier to Stomach? - WebMD, 12/1/05 - "patients
taking Cox-2 inhibitors had no fewer stomach bleeds or ulcers than those
taking traditional NSAIDs"
-
Study
Casts New Doubt On Pain Killer Safety - CBS 2 Chicago, 4/18/05
-
New FDA Labeling for Pfizer's Celebrex, Pfizer Agrees to Suspend Sales of
Bextra - Doctor's Guide, 4/7/05
-
Celebrex Provides A Two Pronged Attack Against Prostate Cancer - Science
Daily, 3/18/05 - "Celebrex, not only targets COX-2,
but also reduces levels of a key protein, cyclin D1, that's critical for
cell replication"
- Study: Low-Dose
Celebrex Poses No Heart Risk - WebMD, 2/17/05
-
COX-2 Inhibitors Associated with Blood Pressure Elevation - Doctor's
Guide, 2/14/05
- Newer Pain
Relievers No Safer for Stomach - WebMD, 1/25/05
-
Celecoxib Shows Surprising Activity Against Estrogen Receptors - Science
Daily, 12/23/04
-
What Should Celebrex And Bextra Patients Do? University Of Michigan Expert
Says There Are Still Plenty Of Options - Science Daily, 12/20/04
- Arthritis Drug May
Prevent Breast Cancer - WebMD, 12/10/04
- Celebrex may be safer than
Vioxx, study finds - MSNBC, 12/6/04
-
Drug May Hinder Recovery From Heart Attacks - Science Daily, 11/18/04
-
Valdecoxib Linked to Cardiovascular Complications - Doctor's Guide,
11/12/04
-
New Worries Tarnishing Arthritis Drugs - Intelihealth, 11/11/04
- Bextra Ups
Heart Attack, Stroke Risk - WebMD, 11/10/04
- Arthritis Drug
May Shrink Breast Cancers - WebMD, 11/5/04
- Celebrex May
Be Safe for Ulcerative Colitis - WebMD, 11/2/04
- Pfizer Warns
of Skin, Heart Risks From Bextra - WebMD, 10/15/04
-
Celecoxib (Celebrex) May Foil Recurrent Prostate Cancer - Doctor's
Guide, 10/13/04
- Vioxx Unsafe:
So What About Similar Drugs? - WebMD, 10/7/04
- Report: Vioxx linked to
thousands of deaths - MSNBC, 10/7/04 -
"Merck & Co.’s arthritis drug Vioxx may have led to
more than 27,000 heart attacks and sudden cardiac deaths before it was
pulled from the market last week"
- Vioxx Fall No
Surprise to Heart Docs - WebMD, 10/1/04
-
Merck Announces Voluntary Worldwide Withdrawal of Vioxx (Rofecoxib) -
Doctor's Guide, 9/30/04
-
FDA Issues Public Health Advisory on Vioxx as its Manufacturer Voluntarily
Recalls the Product - Doctor's Guide, 9/30/04
- Vioxx
Questions and Answers - WebMD, 9/30/04
-
Trial Confirms Overall Benefits of Prexige (Lumiracoxib) Over NSAIDs in
Combined Gastrointestinal and Cardiovascular Safety - Doctor's Guide,
9/29/04
-
COX-2 Valdecoxib Appears To Produce Only Half The Side-Effects But Shows
Double The Compliance Of Non Steroidal Anti-Inflammatory Drugs -
Doctor's Guide, 9/8/04
-
FDA Approves Vioxx (Rofecoxib) for Once-Daily Treatment of Juvenile
Rheumatoid Arthritis - Doctor's Guide, 9/8/04
- More Evidence:
Vioxx Increases Heart Risks - WebMD, 8/26/04
-
Prexige (Lumiracoxib) Appears To Significantly Reduce Gastrointestinal
Events Without Compromising Cardiovascular Safety Compared To Nsaids -
Doctor's Guide, 8/26/04
-
Prexige Significantly Reduces Gastrointestinal Events Without Compromising
Cardiovascular Safety Compared To NSAIDs - Doctor's Guide, 8/20/04
- Lumiracoxib May Be
Useful for Osteoarthritis Without Worsening Cardiac Risk - Medscape,
8/20/04
- New Drug
[Prexige] Treats Arthritis, Easy on Stomach - WebMD, 8/19/04
- Painkiller
Vioxx Often Taken at Too High Dose - WebMD, 7/14/04
-
Vanderbilt Research Shows High Doses Of Popular Pain Reliever Prescribed
Despite Heart Risk - Science Daily, 7/13/04
- Popular
Painkiller May Slow Prostate Cancer - WebMD, 6/11/04
-
Rofecoxib but not Celecoxib Associated With Increased Risk of Oedema and
Blood Pressure Increase - Doctor's Guide, 6/10/04
- Arthritis Drug
Linked to Heart Failure - WebMD, 5/27/04
-
Naproxen Associated With Longer Life Expectancy Than Rofecoxib In Patients
With Rheumatoid Arthritis - Doctor's Guide, 5/14/04
-
Rofecoxib Associated With Increased Acute Myocardial Infarction Risk in
Elderly Patients - Doctor's Guide, 5/6/04
-
A Comparison of the Efficacy of Placebo, Acetaminophen, and Celecoxib in
Patients With Osteoarthritis of the Knee or Hip - Doctor's Guide,
4/27/04
-
Valdecoxib Relieves Dental Pain With Few Adverse Effects - Doctor's
Guide, 4/20/04
-
Once Daily Lumiracoxib as Effective as Celecoxib for Knee Osteoarthritis
- Doctor's Guide, 4/2/04
- Vioxx, Blood
Pressure Medications Don't Mix - WebMD, 3/11/04 -
"taking both Vioxx and high blood pressure
medications doubles the risk of a heart attack"
-
Rofecoxib May Increase Cardiovascular Events Risk in Arthritis Patients on
Antihypertensive Medications - Doctor's Guide, 3/11/04
-
Day or Night Celecoxib Equally Relieve Osteoarthritic Pain - Doctor's
Guide, 2/19/04
-
Celecoxib and Diclofenac Differ In Their 24-Hour Effects on Blood Pressure
- Doctor's Guide, 2/17/04
-
Rofecoxib Not Associated with Increased Risk of Cardiovascular Events or
Death - Doctor's Guide, 10/30/03
-
Licofelone Offers Equal Efficacy With Better Tolerability Than Celecoxib for
Knee Osteoarthritis - Doctor's Guide, 10/28/03
-
Etoricoxib Once Daily May be as Effective as Diclofenac for Treatment of
Rheumatoid Arthritis - Doctor's Guide, 10/28/03
-
12.5 mg/day Rofecoxib First Choice for Knee Osteoarthritis - Doctor's
Guide, 10/28/03
-
Valdecoxib and Rofecoxib Comparable at Two Weeks, Valdecoxib More Effective
in First Six Hours, for Knee Osteoarthritis With Flare - Doctor's Guide,
10/28/03
-
Celecoxib Associated with Fewer Gastrointestinal Claims - Doctor's
Guide, 10/27/03
-
Rofecoxib is Effective Treatment Option for Osteoarthritis Patients that Do
Not Respond to Celecoxib - Doctor's Guide, 10/16/03
-
Rofecoxib as Effective as Naproxen, but Has Better Gastrointestinal
Tolerability - Doctor's Guide, 10/15/03
-
Celecoxib Inhibits Metoprolol Metabolism, But Rofecoxib Does Not -
Doctor's Guide, 9/11/03
-
Incidence Of Cardiovascular Adverse Events Similar Among Patients Treated
With Celecoxib, Nonsteroidal Anti-Inflammatories, Or Placebo - Doctor's
Guide, 9/10/03 -
"For primary cardiovascular events, the relative
risks (RRs) comparing celecoxib with NSAIDs were 1.06 (95% CI 0.70 to 1.61,
p = 0.79) for all patients, and 0.86 (95% CI 0.48 to 1.56, p = 0.62) for
patients not treated with aspirin. The RR comparing celecoxib and placebo
was 0.85"
-
Fewer Confirmed Upper Gastrointestinal Events with Etoricoxib Treatment than
Ibuprofen - Doctor's Guide, 8/29/03
-
Rofecoxib Effective, Tolerable Treatment of Choice for Osteoarthritis -
Doctor's Guide, 7/23/03
-
Low Incidence Of Thromboembolic Events Associated With Rofecoxib And
Meloxicam During Nine Months After Prescription - Doctor's Guide,
7/16/03
-
First Report of Celecoxib-Associated Oesophagitis - Doctor's Guide,
7/11/03
-
Valdecoxib Safe, Effective New Option for Rheumatoid Arthritis Treatment
- Doctor's Guide, 7/10/03
-
Adverse Gastrointestinal Events are Fewer for Celecoxib than Meloxicam -
Doctor's Guide, 7/7/03
-
Rofecoxib Effective in Treating Certain Eye Conditions - Doctor's Guide,
6/11/03
-
Neither Rofecoxib Nor Naproxen Slows Cognitive Decline Of Mild To Moderate
Alzheimer Disease - Doctor's Guide, 6/6/03
-
Arthritis Pain Therapy Using Coxibs is More Expensive Than Using NSAIDs
Despite Gastrointestinal Benefits - Doctor's Guide, 6/5/03
-
Endoscopically Detectable Gastroduodenal Ulcers Less Common in Rheumatoid
Arthritis Patients Taking Rofecoxib Compared to Naproxen - Doctor's
Guide, 5/28/03
-
COX-2 specific Inhibitor Causes Fewer Small Bowel Lesions than Alternative
Arthritis Treatment - Doctor's Guide, 5/23/03
-
Valdecoxib Better Tolerated than Nonsteroidal Anti-inflammatory Drugs for
Arthritis - Doctor's Guide, 5/22/03
-
Celecoxib Reduces Use of GI-Related Health Resources Compared to NSAIDs in
Elderly - Doctor's Guide, 5/22/03
-
Rofecoxib Increases Weight, Blood Pressure in Rheumatoid-Arthritis Patients
- Doctor's Guide, 5/20/03
-
Rofecoxib Shows Sustained Benefit in Osteoarthritis After Two Years -
Doctor's Guide, 5/16/03
-
Little Risk of Hypertension with COX-2 Blockers - Doctor's Guide,
5/16/03
-
Rofecoxib Increases Systolic Blood Pressure in Hypertensives with
Osteoarthritis and Type 2 Diabetes - Doctor's Guide, 5/16/03
-
Greater Reduction In Incidence Rates Of Selected Gastrointestinal Events
With Rofecoxib Compared With Meloxicam - Doctor's Guide, 5/15/03
-
Investigational Arcoxia (Etoricoxib) Relieves Acute Gouty Arthritis Pain As
Well As Indomethacin - Doctor's Guide, 3/20/03
-
Vioxx (Rofecoxib) Provides Acute Pain Relief as Effective as a Commonly
Prescribed Narcotic - Doctor's Guide, 3/20/03
- Celecoxib-Induced
Upper Gastrointestinal Hemorrhage and Ulceration - Medscape, 3/19/03
-
Rofecoxib Appears to Have Earlier Onset of Osteoarthritis Pain Relief -
Doctor's Guide, 2/24/03 -
"Rofecoxib 25 mg achieved a faster onset of efficacy
for osteoarthritis (OA) pain and stiffness than celecoxib 200 mg, and both
COX-2 inhibitors had quicker onset than acetaminophen 4000 mg ... Median
time for good or excellent PGART response was day 3 for rofecoxib 25 mg, day
4 for rofecoxib 12.5 mg, day 5 for celecoxib mg and day 6 for acetaminophen"
- New Arthritis
Drugs May Help Heart - WebMD, 1/13/03
-
Study Questions Celebrex Use For Ulcers - Intelihealth, 12/26/02
- Study Finds
Celebrex No Safer Than NSAIDs in Preventing Recurring Bleeding - WebMD,
12/23/02
- Celecoxib May Improve
Breast Cancer Outcomes - Medscape, 12/16/02
-
Rofecoxib May Not Negatively Affect Blood Pressure in Younger, Healthier
Patients - Doctor's Guide, 12/16/02
-
Hypertension Increases May Be Lower with Celecoxib than with Rofecoxib -
Doctor's Guide, 12/12/02 -
"Elderly patients with
hypertension who take non-steroidal
anti-inflammatory drugs (NSAID) for arthritis or other conditions may see
fewer adverse effects on blood pressure with celecoxib than with rofecoxib"
-
Rofecoxib Has Good Cardiovascular Safety Profile in Older Patients with
Alzheimer's or Cognitive Impairment - Doctor's Guide, 11/20/02
- Arthritis Drug
[Bextra] May Cause Severe Reaction - WebMD, 11/15/02
-
One-Year Results from an Active Comparator-Controlled Trial of Rofecoxib in
Patients with Rheumatoid Arthritis - Doctor's Guide, 10/30/02
-
Valdecoxib Safety Shown Equal to Non-Steroidal Anti-Inflammatory Drugs in
Arthritis Patients - Doctor's Guide, 10/29/02
-
Valdecoxib Effective With or Without Concomitant Medications, Including
DMARDs - Doctor's Guide, 10/29/02
-
Functional Improvement in Chronic Low Back Pain Seen With Etoricoxib Study
- Doctor's Guide, 10/29/02
-
Analysis of Upper Gastrointestinal Events in Clinical Trials with Rofecoxib
Versus Non-Steroidal Anti-Inflammatory Drugs - Doctor's Guide, 10/28/02
-
Further Analysis Shows Risk of Cardiovascular Events Not Significantly
Increased with Rofecoxib - Doctor's Guide, 10/28/02
-
Preoperative Ketorolac More Effective Post-Operatively, Vioxx (Rofecoxib)
More Effective After Patient Discharge - Doctor's Guide, 10/15/02
- Celebrex Stops
Preterm Labor - WebMD, 9/30/02 -
"Celebrex was found to work just as well as the most
common preterm labor drug, but was much safer for mother and baby"
- Arthritis Drug
[Celebrex] Slows ALS in Mice - WebMD, 9/25/02
-
Celebrex May Be Safe For Preterm Labor, Preliminary Study Finds -
Doctor's Guide, 9/24/02
-
Pharmacia and Pfizer Announce FDA Approval For New 400 mg Strength Celebrex®
Capsule for Treatment of Familial Adenomatous Polyposis - Doctor's
Guide, 9/9/02
-
Health Canada Approves Changes to Vioxx (Rofecoxib) Label to Reflect GI
Safety Data from Landmark Study - Doctor's Guide, 8/21/02
-
Etoricoxib Superior to Oxycodone/Acetaminophen for Acute Pain - Doctor's
Guide, 8/21/02
- Celecoxib Safe in
Aspirin-Exacerbated Respiratory Disease - Medscape, 8/6/02
-
COX-2 Specific Inhibitor Bextra (Valdecoxib) Effective And Well-Tolerated
Treatment For Painful Menstrual Cramping - Doctor's Guide, 8/1/02
-
Valdecoxib Receives Positive Opinion In Europe From Committee For
Proprietary Medicinal Products - Doctor's Guide, 7/26/02
-
Dog's tale of survival opens door in cancer research - USA Today,
7/24/02 -
"When researchers heard that Navy was cancer-free
after receiving a cocktail of drugs already approved by the Food and Drug
Administration — Celebrex,
tamoxifen (sold as Nolvadex) and doxycycline
— the treatment became known as the Navy Protocol ... Navy's treatment,
though experimental, cost $2,000"
- Celecoxib Helpful
Add-On Therapy in Schizophrenia - Doctor's Guide, 6/28/02
-
Blood Pressure Changes with Non-Steroidal Anti-Inflammatory Drugs Measured
- Doctor's Guide, 6/26/02
-
Etoricoxib an Effective Alternative to Indometacin for Gouty Arthritis -
Doctor's Guide, 6/24/02
-
Long-Term Treatment of Osteoarthritis with Vioxx (Rofecoxib) and Diclofenac
Continues to be Effective - Doctor's Guide, 6/19/02
-
Adverse Cardiovascular Events with Rofecoxib Similar to Placebo in Elderly
Population - Doctor's Guide, 6/19/02
-
Vioxx (Rofecoxib) Safer than Naproxen for Lower Gastrointestinal Tract in
Older Rheumatoid Arthritis Patients - Doctor's Guide, 6/19/02
-
New COX-2 Inhibitor Etoricoxib Looks Promising for Back Pain, Rheumatoid
Arthritis and Acute Gouty Arthritis - Doctor's Guide, 6/17/02
-
Celecoxib Treatment Results in Fewer Adverse Events and Therefore Costs Less
than Rofecoxib and Traditional NSAIDs - Doctor's Guide, 6/17/02
-
Edema Rates May be Higher with Rofecoxib than other Common NSAIDs -
Doctor's Guide, 6/17/02
-
Channeling and Reporting Bias Evident in Observational Studies of GI
Toxicity with Meloxicam and COX-2 Inhibitors - Doctor's Guide, 6/17/02
-
Physicians Favor Celebrex (Celecoxib) for Patients with High Cardiovascular
Risk - Doctor's Guide, 6/17/02
-
Patients with Rheumatic Diseases Stick to COX-2 Inhibitor Therapy More than
Traditional NSAIDs - Doctor's Guide, 6/17/02
-
Rofecoxib Linked to Hypertension in Patients with Rheumatoid Arthritis and
Osteoarthritis - Doctor's Guide, 6/17/02
-
Valdecoxib Beats out Ibuprofen and Diclofenac with Respect to Dyspepsia
Symptoms in Osteoarthritis Patients - Doctor's Guide, 6/17/02
-
Celebrex (Celecoxib) a More Satisfactory Treatment than NSAIDS, According to
Osteoarthritis Patients - Doctor's Guide, 6/17/02
-
Celecoxib Found as Effective as Diclofenac for Pain from Ankle Sprain -
Doctor's Guide, 6/14/02
-
FDA Approves New Celebrex (Celecoxib) Prescribing Information; New Data
Included From CLASS Study - Doctor's Guide, 6/7/02
-
Highly Sensitive COX-2 Inhibitor, Etoricoxib, Effective In Treating
Rheumatoid Arthritis Pain - Doctor's Guide, 6/7/02
-
Study Finds Two Expensive Pain Relievers Often Prescribed When Cheaper
Medicines Would Suffice - Intelihealth, 6/4/02 -
"The drugs - Vioxx and Celebrex - are heralded for
their ability to relieve pain without the gastrointestinal upsets of older,
cheaper drugs like ibuprofen or naproxen. However, the study found that 76
percent of prescriptions written are for patients who show no risk of such
side effects"
- Experts
Question Safety of Arthritis Drug - WebMD, 5/30/02 -
"The published report of the Celebrex Long Term
Arthritis Safety Study (CLASS), sponsored by the drug's manufacturer,
concluded that people taking Celebrex for six months had lower rates of
stomach and intestinal ulcers than those taking two older arthritis drugs -
diclofenac and
ibuprofen. But the study actually lasted
for a year, and the summary ignored later data showing no safety advantage
for the newer drug"
-
Painkillers May Delay Bone Healing - Intelihealth, 5/28/02
-
Celecoxib Plus Standard Chemotherapy Results in High Response Rate in
Non-Small Cell Lung Cancer - Doctor's Guide, 5/22/02
- Popular Arthritis
Drug [Celebrex] KO's Lung Cancer - WebMD, 5/21/02 -
"In a small study of 16 patients with early
cancer than had not spread beyond the lungs,
patients who took Celebrex along with
chemotherapy benefited from the treatment, and the cancer virtually
disappeared in five patients ... In eight other patients, tumors shrank, and
four more patients had stable disease ... The expected complete clinical
response rate -- meaning that tumors are no longer visible by X-ray -- with
the chemotherapy alone "is just 1%, so these results were very
encouraging.""
- Vioxx Safer on
Lower Digestive Tract, Too - WebMD, 5/21/02
-
Patients With Juvenile Rheumatoid Arthritis Respond Well To Meloxicam -
Doctor's Guide, 5/15/02
-
Fewer Gastrointestinal Events Seen With Cox-2 Inhibitors - Doctor's
Guide, 5/8/02
-
New COX-2 Specific Inhibitor Valdecoxib Compared to Oxycodone/Acetaminophen
for Pain Relief After Dental Surgery - Doctor's Guide, 5/8/02
-
Drug dilemma confronts users of painkillers - USA Today, 4/14/02 -
"Arthritis patients looking for pain relief may
start feeling as if they have to choose between two evils: a
bleeding ulcer from some drugs, maybe a higher risk of
heart attack from another"
-
FDA Approves Label Changes for Vioxx (Rofecoxib), Endorses New Indication
for Adult Rheumatoid Arthritis - Doctor's Guide, 4/11/02
-
Bextra (Valdecoxib) Now Widely Available in U.S. for Arthritis
Pain/Inflammation and Menstrual Cramping - Doctor's Guide, 4/10/02
- Pain Drug Vioxx
Linked to Meningitis - WebMD, 3/25/02
-
Bextra (Valdecoxib) Shows Promise in Relieving Post-Surgical Dental Pain
- Doctor's Guide, 3/25/02
-
Dysmenorrhea Improves with Etoricoxib - Doctor's Guide, 3/18/02
-
Tramadol/Acetaminophen Helpful as Add-On Therapy for Arthritis Patients
Taking COX-2 NSAIDS - Doctor's Guide, 3/18/02
-
Vioxx (Rofecoxib) Relieves Acute Pain from Dental Surgery Better than
Oxycodone/Acetaminophen Combination - Doctor's Guide, 3/4/02
- Vioxx (Rofecoxib) Shows
Osteoarthritis Pain Relief Superior to Celebrex (Celecoxib) or Acetaminophen
- Doctor's Guide, 1/8/02
-
Rofecoxib Offers Advantages in Treatment of Knee Osteoarthritis -
Doctor's Guide, 1/3/02
- FDA Approves Bextra
(Valdecoxib) for Pain/Inflammation of Arthritis and Menstrual Cramps -
Doctor's Guide, 11/19/01
- Rheumatoid Arthritis Drug
Rofecoxib May Raise Blood Pressure Significantly - Doctor's Guide,
11/16/01
- Celebrex (Celecoxib)
Reduces Gastrointestinal-Related Health Care Resource Use Compared to
Diclofenac and Naproxen - Doctor's Guide, 11/14/01
- Celebrex (Celecoxib)
Provides Similar Efficacy and Improved Safety Compared to Diclofenac and
Naproxen - Doctor's Guide, 11/14/01
- Celebrex (Celecoxib)
Brings No Increased Risk of Adverse Cardiovascular Events Compared to
Ibuprofen, Diclofenac, Naproxen - Doctor's Guide, 11/13/01
- Celebrex (Celecoxib) as
Effective/Safer Than Two Traditional Non-steroidal Anti-inflammatories in
Osteoarthritis - Doctor's Guide, 11/13/01
- Celebrex (Celecoxib) 200
mg Comparable To Vioxx (Rofecoxib) 25 mg in Osteoarthritis Study -
Doctor's Guide, 11/13/01
- FDA Approves Celebrex
(Celecoxib) for Acute Pain Relief - Doctor's Guide, 10/22/01
- Pharmacia/Pfizer: Celebrex
Safety Profile Well-Established - Doctor's Guide, 8/23/01
- Merck Stands Behind
Cardiovascular Safety Profile of Vioxx (Rofecoxib) - Doctor's Guide,
8/22/01
- Pharmacia and Pfizer
Address Article in August 22/29 Issue of The Journal of the American Medical
Association - Doctor's Guide, 8/22/01
- Popular Anti-Inflammatory
Drugs May Increase Risk of Cardiovascular Events - Doctor's Guide,
8/22/01
-
Report Suggests Heart Link With Celebrex, Vioxx, But Critics Say More
Research Needed - Intelihealth, 8/21/01 -
"The popular and heavily promoted new arthritis
drugs Vioxx and Celebrex have been linked by researchers to a small but
troubling increase in the risk of heart attacks and strokes"
- Safety of
Arthritis Drugs in Question - WebMD, 7/10/01 -
"the cardiovascular safety of Vioxx and Celebrex,
another COX-2 inhibitor, has been questioned; and a report published in a
recent issue of The Lancet suggests this group of drugs also can harm the
kidneys"
- Arthritis Drug
[Vioxx] May Help Migraines - WebMD, 6/29/01
- Debate Separates Hype From
Evidence In Cox-2 Inhibitor Competition - Doctor's Guide, 6/17/01
- Mobicox (Meloxicam) Shows
High Rate of Patient Satisfaction In Osteoarthritis - Doctor's Guide,
6/15/01
- Rofecoxib Demonstrates
Fewer Gastrointestinal Complications Than Naproxen Over One Year -
Doctor's Guide, 6/15/01
- Celecoxib 200 mg and
Rofecoxib 25 mg Have Comparable Efficacy in Osteoarthritis - Doctor's
Guide, 6/14/01
- Celecoxib as Effective,
Safer Than Diclofenac and Naproxen for Osteoarthritis - Doctor's Guide,
6/14/01
- Celecoxib Provides Better
Pain Control Than Diclofenac In Osteoarthritis And Rheumatoid Arthritis
Patients - Doctor's Guide, 6/14/01
- Fewer Treatment-Limiting
Gastrointestinal Side Effects With Vioxx (Rofecoxib) Than Naproxen for
Osteoarthritis - Doctor's Guide, 6/14/01
- COX-2 Inhibitor,
Celecoxib, as Effective and Safe as Naproxen and Diclofenac - Doctor's
Guide, 6/14/01
- Pivotal Studies Show
Differences Between COX-2 Inhibitors In Renal And Hypertensive Effects -
Doctor's Guide, 6/14/01
- Further Evidence Supports
GI Safety, Upper GI Tolerability Of Celecoxib Compared With NSAIDs -
Doctor's Guide, 5/25/01
- Favourable Cardiovascular
Safety Profile Confirmed for Vioxx (Rofecoxib) - Doctor's Guide, 5/23/01
- Celebrex (Celecoxib),
Vioxx (Rofecoxib) Produce Different Blood Pressure/Edema Effects in
Osteoarthritis Patients - Doctor's Guide, 5/11/01 -
"more patients taking Vioxx® (rofecoxib) experienced
statistically significant and clinically important increases in systolic
blood pressure (SBP) and edema versus patients taking Celebrex®
(celecoxib)."
-
Study Focuses On Arthritis Drugs - Intelihealth, 5/12/01 -
"Patients taking the anti-arthritis drug Vioxx are
more likely to suffer high-blood pressure and swelling than patients taking
Celebrex"
- Once Daily Vioxx
(Rofecoxib) Significantly Reduces Chronic Low Back Pain - Doctor's
Guide, 4/23/01
- Parecoxib Appears As
Effective As Ketorolac, Morphine In Reducing Knee Surgery Pain -
Doctor's Guide, 4/22/01 -
"40 mg of intravenous parecoxib provides equivalent
pain relief for up to 24 hours as did ketorolac, the only available
intravenous (IV) non-steroidal anti-inflammatory drug ... In addition,
parecoxib, an investigational cyclooxygenase (COX-2) inhibitor, was
statistically significantly more effective in controlling pain than 4 mg of
morphine, 20 mg of parecoxib and placebo"
- Rofecoxib Better Than
Combination Acetaminophen/Codeine For Acute Pain Control - Doctor's
Guide, 4/22/01 -
"Rofecoxib [Vioxx] was superior to the narcotic
combination in total pain relief over six hours, in peak pain relief, in the
patient's own assessment of pain relief and in the time required to take
rescue medication"
- Another Link Between Cox-2
Expression and Breast Cancer - Doctor's Guide, 3/29/01 -
"This finding leaves the door open to studies that
would determine whether treatment with COX-2 inhibitors might somehow affect
tumor progression"
- Anti-Inflammatory Vioxx
(Rofecoxib) May Raise Blood Pressure, No Such Increase Seen With Celebrex
(Celecoxib) - Doctor's Guide, 3/20/01
- Studies Target Link
Between COX-2 and Ovarian Cancer - Doctor's Guide, 3/8/01
- Celebrex (Celecoxib)
Effective In Treating Ankle Sprains - Doctor's Guide, 3/6/01
- Differentiating Coxibs
From Nonsteroidal Anti-Inflammatory Drugs - Doctor's Guide, 2/19/01
- Cox 2 Drugs, Biologic
Therapy Agents Usher New Era Of Arthritis Treatment - Doctor's Guide,
2/18/01 -
"The advantage is not so much that they work better
but they are much safer. In terms of GI (gastrointestinal) tract, they have
a much lower incidence of causing ulcers and complications of ulcers, such
as bleeding, perforation, obstruction etc."
-
FDA Warned About Arthritis Drug - Intelihealth, 2/8/01
- FDA
action could give boost to Celebrex, Vioxx - USA Today, 2/6/01
-
Rofecoxib's Gastrointestinal Toxicity Reviewed - Doctor's Guide, 1/24/01
- COX-2 Inhibition -
Oncology Findings - Doctor's Guide, 12/7/00
- Recent Gastrointestinal
Outcomes With COX-2 Specific Inhibitors -- Clinical Implications -
Doctor's Guide, 12/7/00
- Differentiating Between
COX-2 Specific Inhibitors - Doctor's Guide, 12/7/00
- COX-2-specific Inhibition
In Musculoskeletal Pain And Inflammation - Clinical Update - Doctor's
Guide, 12/7/00
- Drugs Usher in
Era of Hope for Rheumatoid Arthritis Sufferers, New Drugs May Even Prevent
Joint Damage - WebMD, 11/29/00
- Rofecoxib Proves More
Effective Than Celecoxib And Acetaminophen For Knee Pain - Doctor's
Guide, 11/3/00
- Vioxx (Rofecoxib)
Significantly Reduces Pain After Dental Surgery - Doctor's Guide,
11/3/00
- Better Gastrointestinal
Profile For Rofecoxib Than Naproxen In Rheumatoid Arthritis - Doctor's
Guide, 11/1/00
- Celebrex (Celecoxib)
Comparable To Vioxx (Rofecoxib) In Osteoarthritis Treatment - Doctor's
Guide, 10/30/00
-
Side-Effect Warning For Novel Arthritis Drug - Intelihealth, 10/10/00
- Arthritis Drug
Easy on the Stomach, Study Confirms - WebMD, 9/12/00
- Celecoxib Not Associated
With GI Toxicity, Increased Cardiovascular Risk Seen With Conventional
NSAIDs - Doctor's Guide, 7/10/00
- Rofecoxib Associated With
Greater Blood Pressure Increases And Oedema Than Celecoxib - Doctor's
Guide, 7/10/00
- No Significant Differences
In Adverse Effects Between Vioxx (Rofecoxib) And Celecoxib For
Osteoarthritis - Doctor's Guide, 6/23/00
- Celebrex (Celecoxib) For
Arthritis Shows No Increased Risk For Thromboembolic Or
Cardiovascular-Related Events - Doctor's Guide, 6/22/00
- Vioxx (Rofecoxib) Reduces
Night-Time Osteoarthritis Pain Better Than Celecoxib Or Acetaminophen -
Doctor's Guide, 6/22/00
- Osteoarthritis Drug
Celebrex (Celecoxib) Less Likely To Cause Increased Blood Pressure Than
Vioxx (Rofecoxib) - Doctor's Guide, 6/22/00
- COX-2 Inhibitors Show Good
Pain Relief, Safety Record - Doctor's Guide, 6/2/00
- No Link Between GI
Complications And Celebrex (Celecoxib) - Doctor's Guide, 5/23/00
- Cardiovascular safety
profile of Vioxx (rofecoxib) confirmed - Doctor's Guide, 5/1/00
- Celebrex (Celecoxib) Not
Associated With Increases In Stroke Or Heart Attacks - Doctor's Guide,
4/28/00
- Long-Term Celebrex
(Celecoxib) Safer than Ibuprofen or Diclofenac For Arthritis - Doctor's
Guide, 4/17/00
- Mobic (Meloxicam) Approved
in US for Osteoarthritis - Doctor's Guide, 4/14/00
- Some Drugs May Protect
Against Alzheimer's, Others Might Increase Risk - Doctor's Guide,
4/12/00
- Study Shows Celecoxib Not
Useful In Preventing Alzheimer's Dementia - Doctor's Guide, 4/10/00
- Celebrex (Celecoxib)
Once-Daily For Osteoarthritis As Effective As Twice-Daily Dose -
Doctor's Guide, 4/6/00
- Vioxx (Rofecoxib) Causes
Fewer GI Events Than Naproxen In Rheumatoid Arthritis Patients -
Doctor's Guide, 3/27/00
- No Drug Reactions In
Aspirin-Sensitive Patients Taking COX-2 Inhibitors, Says Researcher -
Doctor's Guide, 3/6/00
- Platelet Function In
Osteoarthritis Patients Is Not Affected By Celebrex - Doctor's Guide,
2/15/00
-
Serendipity And Hope In War On Cancer - Intelihealth, 1/18/99
- FDA Approved Celebrex In
Adjunct Therapy For Familial Adenomatous Polyposis - Doctor's Guide,
12/23/99
- Vioxx, For OA Symptoms,
Has Fewer GI Problems When Compared To NSAIDs - Doctor's Guide, 11/23/99
- Rofecoxib Has Fewer GI
Side Effects Than NSAIDs In OA Patients - Doctor's Guide, 11/23/99
- Celecoxib Effective In
Rheumatoid Arthritis, With Fewer Ulcers Than Naproxen - Doctor's Guide,
11/23/99
- Rofecoxib Requires Less GI
Intervention In Osteoarthritis Patients - Doctor's Guide, 11/18/99
- Osteoarthritis Patients
Taking Vioxx Experience Fewer GI Complications - Doctor's Guide,
11/17/99
- Celecoxib Safer Than
Traditional Analgesics For Chronic Conditions - Doctor's Guide, 11/17/99
- Celebrex Well Tolerated
Across Wide Range Of Studied Doses - Doctor's Guide, 11/16/99
- Celebrex Helps Ease
Arthritis Symptoms In Elderly Patients - Doctor's Guide, 11/16/99
- Celebrex Provides Relief
From Post-Operative Pain - Doctor's Guide, 10/25/99
- Celecoxib As Effective As
Naproxen In Relieving Hip Pain - Doctor's Guide, 10/25/99
- Celecoxib Reduces Number
And Size Of Colorectal Polyps - Doctor's Guide, 10/21/99
- Upper GI Healing
Unaffected By COX-2 Inhibitors, At Least For Erosions - Doctor's Guide,
10/19/99
- Osteoarthritis Drug,
Vioxx, Relieves Menstrual Pain - Doctor's Guide, 10/19/99
- COX-2 Inhibitors Shown
Effective For Reducing Risk of Colon Cancer - Doctor's Guide, 10/18/99
- COX-2 Inhibitors Have
Fewer GI Side Effects Than Other NSAIDs - Doctor's Guide, 10/18/99
- FDA Grants Priority Review
For New Indication For Celebrex For Use In FAP - Doctor's Guide, 9/2/99
- Celebrex Effective In RA,
OA Without Affecting Platelet Function, Clotting - Doctor's Guide,
6/9/99
- Vioxx Now Available In
U.S. For Menstrual Pain, Osteoarthritis - Doctor's Guide, 6/9/99
- Searle & Pfizer Refute
Merck's Claims About Benefits Of Vioxx - Doctor's Guide, 6/9/99
- FDA Approves Vioxx For
Osteoarthritis, Acute Pain In Adults And Menstrual Pain - Doctor's
Guide, 5/21/99
- Vioxx Causes Significantly
Fewer Ulcers Than Standard NSAIDs - Doctor's Guide, 5/17/99
- Searle Responds to Journal
Report On Celebrex Side Effects - Doctor's Guide, 4/22/99
- Report Submitted To FDA On
Risks Linked To Celebrex - Doctor's Guide, 4/21/99
- Vioxx As Effective As
High-Dose Traditional Medications For Acute Pain - Doctor's Guide,
3/18/99
- Rofecoxib As Effective As
NSAIDs For Pain, Inflammation - Doctor's Guide, 2/25/99
- Celebrex Now Available In
The U.S. For Arthritis Treatment - Doctor's Guide, 2/23/99
- FDA Approves Celebrex For
Osteoarthritis And Rheumatoid Arthritis - Doctor's Guide, 1/4/1999
- FDA
approves first drug in new class of painkillers - CNN, 12/31/98
- Studies Show Vioxx Does Not
Damage Gastrointestinal Tract - Doctor's Guide, 10/13/98
- Vioxx Enables Arthritis
Patients To Better Carry Out Daily Activities - Doctor's Guide, 9/8/98
- Vioxx Relieves Dental,
Menstrual And Arthritis Pain - Doctor's Guide, 4/21/98
Related Searches:
Related Sites:
70729
|
|